These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27481136)

  • 1. Quality Issues with Public Domain Chemogenomics Data.
    Kalliokoski T; Kramer C; Vulpetti A
    Mol Inform; 2013 Dec; 32(11-12):898-905. PubMed ID: 27481136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemogenomics approaches for receptor deorphanization and extensions of the chemogenomics concept to phenotypic space.
    van der Horst E; Peironcely JE; van Westen GJ; van den Hoven OO; Galloway WR; Spring DR; Wegner JK; van Vlijmen HW; Ijzerman AP; Overington JP; Bender A
    Curr Top Med Chem; 2011; 11(15):1964-77. PubMed ID: 21470175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual Analysis of Biological Activity Data with Scaffold Hunter.
    Klein K; Koch O; Kriege N; Mutzel P; Schäfer T
    Mol Inform; 2013 Dec; 32(11-12):964-75. PubMed ID: 27481142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemogenomic Active Learning's Domain of Applicability on Small, Sparse qHTS Matrices: A Study Using Cytochrome P450 and Nuclear Hormone Receptor Families.
    Rakers C; Najnin RA; Polash AH; Takeda S; Brown JB
    ChemMedChem; 2018 Mar; 13(6):511-521. PubMed ID: 29211346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprint.
    Bender A; Young DW; Jenkins JL; Serrano M; Mikhailov D; Clemons PA; Davies JW
    Comb Chem High Throughput Screen; 2007 Sep; 10(8):719-31. PubMed ID: 18045083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Survey of Web-Based Chemogenomic Data Resources.
    Al Mahmud R; Najnin RA; Polash AH
    Methods Mol Biol; 2018; 1825():3-62. PubMed ID: 30334202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benchmarking a Wide Range of Chemical Descriptors for Drug-Target Interaction Prediction Using a Chemogenomic Approach.
    Sawada R; Kotera M; Yamanishi Y
    Mol Inform; 2014 Dec; 33(11-12):719-31. PubMed ID: 27485418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL; Ji L; Li YD
    Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemogenomics and biotechnology.
    Wuster A; Madan Babu M
    Trends Biotechnol; 2008 May; 26(5):252-8. PubMed ID: 18346803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CompoundProtein Interaction Prediction Within Chemogenomics: Theoretical Concepts, Practical Usage, and Future Directions.
    Brown JB; Niijima S; Okuno Y
    Mol Inform; 2013 Dec; 32(11-12):906-21. PubMed ID: 27481137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular response to drug perturbation is limited: comparison of large-scale chemogenomic fitness signatures.
    Barazandeh M; Kriti D; Nislow C; Giaever G
    BMC Genomics; 2022 Mar; 23(1):197. PubMed ID: 35277135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferring Chemogenomic Features from Drug-Target Interaction Networks.
    Yamanishi Y
    Mol Inform; 2013 Dec; 32(11-12):991-9. PubMed ID: 27481144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemogenomics of allosteric binding sites in GPCRs.
    Gloriam DE
    Drug Discov Today Technol; 2013; 10(2):e307-13. PubMed ID: 24050282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ExCAPE-DB: an integrated large scale dataset facilitating Big Data analysis in chemogenomics.
    Sun J; Jeliazkova N; Chupakin V; Golib-Dzib JF; Engkvist O; Carlsson L; Wegner J; Ceulemans H; Georgiev I; Jeliazkov V; Kochev N; Ashby TJ; Chen H
    J Cheminform; 2017; 9():17. PubMed ID: 28316655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Approaches to Target Fishing and Ligand Profiling.
    Rognan D
    Mol Inform; 2010 Mar; 29(3):176-87. PubMed ID: 27462761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capturing structure-activity relationships from chemogenomic spaces.
    Wendt B; Uhrig U; Bös F
    J Chem Inf Model; 2011 Apr; 51(4):843-51. PubMed ID: 21410249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action.
    Ganter B; Tugendreich S; Pearson CI; Ayanoglu E; Baumhueter S; Bostian KA; Brady L; Browne LJ; Calvin JT; Day GJ; Breckenridge N; Dunlea S; Eynon BP; Furness LM; Ferng J; Fielden MR; Fujimoto SY; Gong L; Hu C; Idury R; Judo MS; Kolaja KL; Lee MD; McSorley C; Minor JM; Nair RV; Natsoulis G; Nguyen P; Nicholson SM; Pham H; Roter AH; Sun D; Tan S; Thode S; Tolley AM; Vladimirova A; Yang J; Zhou Z; Jarnagin K
    J Biotechnol; 2005 Sep; 119(3):219-44. PubMed ID: 16005536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the accuracy of chemogenomic models with a three-dimensional binding site kernel.
    Meslamani J; Rognan D
    J Chem Inf Model; 2011 Jul; 51(7):1593-603. PubMed ID: 21644501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the chemogenomic knowledge space with annotated chemical libraries.
    Savchuk NP; Balakin KV; Tkachenko SE
    Curr Opin Chem Biol; 2004 Aug; 8(4):412-7. PubMed ID: 15288252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarity metrics for ligands reflecting the similarity of the target proteins.
    Schuffenhauer A; Floersheim P; Acklin P; Jacoby E
    J Chem Inf Comput Sci; 2003; 43(2):391-405. PubMed ID: 12653501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.